Design Therapeutics

Three Biopharma Companies Making Their Nasdaq Debut
BioSpace
Mon, 03/29/21 - 10:49 am
IPOs
NASDAQ
Design Therapeutics
Edgewise Therapeutics
Ikena Oncology
Design Therapeutics launches with $45m to develop a new class of disease-modifying therapies for serious degenerative disorders
Pharmaceutical Business Review
Mon, 03/23/20 - 11:36 am
Design Therapeutics
degenerative diseases
Fragile X syndrome
myotonic muscular dystrophy